Clinical trial
NAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down Syndrome
NCT07278492
Study timeline
Study start (estimated)2026-08-31Date precision: day
Registry last updated2026-08-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Down Syndrome (DS)unresolved
Interventions
Sponsors & collaborators
Brigham and Women's Hospitallead sponsor
National Institutes of Health (NIH)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07278492 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.